Represented Redwoods Acquisition Corp. in its merger with Anew Medical Inc., an early-stage biotechnology company focused on developing disruptive new therapies to treat neurodegenerative diseases.
-
Co-Chair, Capital Markets & Corporate; Co-Chair, SPACs -
Co-Chair, Life Sciences -